Human genomics of acute liver failure due to hepatitis B virus infection: An exome sequencing study in liver transplant recipients.


Journal

Journal of viral hepatitis
ISSN: 1365-2893
Titre abrégé: J Viral Hepat
Pays: England
ID NLM: 9435672

Informations de publication

Date de publication:
02 2019
Historique:
received: 07 07 2018
revised: 05 09 2018
accepted: 10 09 2018
pubmed: 14 10 2018
medline: 27 6 2020
entrez: 14 10 2018
Statut: ppublish

Résumé

Acute liver failure (ALF) or fulminant hepatitis is a rare, yet severe outcome of infection with hepatitis B virus (HBV) that carries a high mortality rate. The occurrence of a life-threatening condition upon infection with a prevalent virus in individuals without known risk factors is suggestive of pathogen-specific immune dysregulation. In the absence of established differences in HBV virulence, we hypothesized that ALF upon primary infection with HBV could be due to rare deleterious variants in the human genome. To search for such variants, we performed exome sequencing in 21 previously healthy adults who required liver transplantation upon fulminant HBV infection and 172 controls that were positive for anti-HBc and anti-HBs but had no clinical history of jaundice or liver disease. After a series of hypothesis-driven filtering steps, we searched for putatively pathogenic variants that were significantly associated with case-control status. We did not find any causal variant or gene, a result that does not support the hypothesis of a shared monogenic basis for human susceptibility to HBV-related ALF in adults. This study represents a first attempt at deciphering the human genetic contribution to the most severe clinical presentation of acute HBV infection in previously healthy individuals.

Identifiants

pubmed: 30315682
doi: 10.1111/jvh.13019
doi:

Substances chimiques

Hepatitis B Antibodies 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

271-277

Informations de copyright

© 2018 John Wiley & Sons Ltd.

Auteurs

Samira Asgari (S)

School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
Swiss Institute of Bioinformatics, Lausanne, Switzerland.
Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Nimisha Chaturvedi (N)

School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
Swiss Institute of Bioinformatics, Lausanne, Switzerland.

Petar Scepanovic (P)

School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
Swiss Institute of Bioinformatics, Lausanne, Switzerland.

Christian Hammer (C)

School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
Swiss Institute of Bioinformatics, Lausanne, Switzerland.

Nasser Semmo (N)

Department for BioMedical Research, Hepatology, University of Bern, Bern, Switzerland.

Emiliano Giostra (E)

Department of Gastroenterology and Hepatology, Geneva University Hospital, Geneva, Switzerland.

Beat Müllhaupt (B)

Department of Gastroenterology and Hepatology, University Hospital Zürich, Zürich, Switzerland.

Peter Angus (P)

Gastroenterology and Hepatology Department, Austin Health and the University of Melbourne, Melbourne, Victoria, Australia.

Alexander J Thompson (AJ)

Department of Gastroenterology, St Vincent's Hospital, University of Melbourne, Melbourne, Australia.

Darius Moradpour (D)

Service of Gastroenterology and Hepatology, Lausanne University Hospital, Lausanne, Switzerland.

Jacques Fellay (J)

School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
Swiss Institute of Bioinformatics, Lausanne, Switzerland.
Precision Medicine Unit, Lausanne University Hospital, Lausanne, Switzerland.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH